South Korea’s IP-backed lending market growth exceeds targets
Although heavy reliance on government-backed initiatives creates uncertain future for IP holders
Although heavy reliance on government-backed initiatives creates uncertain future for IP holders
The Korean chemicals giant will do anything to combat “harsh competition” and IP is one of the “crucial” tools for securing success, contends IP head Kyung-Hwa Min
The global scientific and engineering consultancy has bought TechPats, a patent-focused technical expert firm, at a time when an uncertain economy and declining number of M&As has led some companies to issue layoff notices to IP staff
Tech+IP Capital report proposes new methodology for looking at patent portfolio geography, finding Qualcomm’s 4G holdings have unmatched reach
02 June 2022
Company now exploring other options after proposed buyer fails to secure financing by the end of May deadline
01 June 2022
The world’s pre-eminent event focusing on IP value creation takes place in Chicago from 12 to 14 June with over 500 senior delegates set to attend
19 May 2022
Analysis from Stout suggests rates sought by certain Enhanced Voice Services (EVS) patent owners are out of line with the overall 3G/4G/5G FRAND landscape
18 May 2022
Terran Biosciences has emerged from obscurity to snap up slew of IP rights in the past two months
04 May 2022
Patent litigators who represent plaintiffs and defendants agree the new standing order favours the defence, but one litigation financier predicts well-financed patentees backed by reputable lenders will get the upper hand
29 April 2022
The latest wireless standard hasn’t yet found its ‘killer app’ for consumers, and it’s affecting licensing negotiations
23 April 2022
Patent brokers and litigation financiers say that over the past year there is a growing trend of lawsuit funders exploring the idea of acquiring their own patent portfolios for monetisation through licensing or litigation
20 April 2022
Hedonic regression is a dependable and impartial way to estimate the value of a standardised technology. Further, it can be applied to a range of products, especially those with multiple features.
13 April 2022
Following major US CRISPR decision, Michael Arciero, VP of IP at ERS Genomics, tells IAM that tricky patent landscapes are the new normal in biotech
04 April 2022
Unlock unlimited access to all IAM content